Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC,
immune checkpoint
statistical data, severe COVID-19 with
immune-system hyperactivity is observed mainly in elderly people
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) , differentiation, as well as
immune response and inflammation. Recently, biological microarray technologies have
Khusnutdinova, E.K.,
Dzhemileva, L.U.,
Lobov, S.L.,
Kuznetzov, D.U.,
Nazirova, A.G.,
Nurgalina, E.M.,
Barashkov, N.A.,
Fedorova, S.A. (2017) . New
approaches are developed to
prevent hereditary sensorineural hearing loss
and to improve medical
1C, GABBR2, TCF7L2, DCK, NRP1, PBX1, FANCC, CCDC88C, TCF12, and ABLIM1 genes.
Prevention